AZ Spotlight | ESC 2024 Hybrid Congress

AZ Spotlight | ESC 2024 Hybrid Congress

The "ESC 2024" provides a dynamic program showcasing cutting-edge data delivered by top experts in the field. The event culminates in an engaging Roundtable Discussion, where specialists will update you on groundbreaking new research and explore its implications for your region.

Dive into the latest advancements in Heart Failure, addressing its crucial role as a global health challenge. Discover the transformative potential of targeted therapies and gain valuable perspectives from leading cardiologists on recent treatment innovations and patient outcomes.

 

ESC 2024 Hybrid Congress Highlights:

  Section
Topic Speakers
 
1 Roundtable Discussion
  • What’s new in HF management
  • Prof. John Amerena
  • Groundbreaking Study
  • Prof. Ragy Hany Ibrahim
  • Key Take Aways
  • Prof. David Sim
  • Dr. Hani Sabbour
  • Dr. Genaro Menoza
[watch now]
  Highlights    
1 Hot Line
  • HELIOS-B study update
  • Prof. Tian Zhuang
  • STOP-or-NOT trial, ABYSS trial
  • Prof. John Amerena
  • Discusses-vutrisiran in patients with ATTR with CM
  • Dr. Hany Ragi
  • Discusses HELIOS-B study in first and Eliminating Rheumatic heart disease from Africa- how can we do that?
  • Dr. Hany Ragi
  • The HELIOS-B study update
  • Dr. Pedro Schwartzmann
  • Discusses updates on late breaking trial STOP-or-NOT
  • Dr. Pedro Schwartzmann
  • Talks about FINEARTS-HF and its clinical implication
  • Prof. David Sim
  • Discusses HELIOS-B study update
  • Dr. Ramzi Tabbalat
  • Talks about the STEP program update
  • Dr. Mikhail Kosiborod
  • Discusses the FINEARTS-HF update
  • Dr. Mikhail Kosiborod
[watch now]
2 Guideline
  • The 2024 ESC Guidelines for the Management of Elevated BP and Hypertension
  • Dr. Alta Schutte
  • The 2024 ESC Guidelines for the Management of Chronic Coronary Syndromes
  • Dr. Markus Schlaich
  • Dr. Jagdish Mohan
[watch now]
3 Hypertension
  • Timing of antihypertensive treatment: The BedMed and BedMed-Frail RCTs
  • Dr. Alta Schutte
  • Discuss FDC in antihypertensive treatment: GMRx2 and QUADRO
  • Dr. Markus Schlaich
[watch now]
4 Heart Failure
  • New updates from GLP studies
  • Dr. Hani Sabbour
  • Biomarkers to guide the treatment of heart failure: where are we going?
  • Dr. Hani Sabbour
  • Updates from STEP program
  • Dr. Subodh Verma
  • Discusses evidence in HF and call to action from ESC 2024
  • Dr. Subodh Verma
[watch now]
5 Coronary Artery Disease
  • Discusses the effects of Coronary Artery Calcium-Guided Statin Therapy on Atherosclerotic Progression in Intermediate-Risk People with Familial Coronary Artery Disease
  • Dr. Manuel Gaxiola
[watch now]

Roundtable Discussion

Roundtable Topic Coverage:

  • What’s new in HF management
  • Groundbreaking Study
  • Key Take Aways

 

Speakers:

  • Prof. John Amerena
    Barwon Health, Australia
  • Prof. Ragy Hany Ibrahim
    National Heart Institute, Egypt
  • Prof. David Sim
    National Heart Centre, Singapore
  • Dr. Hani Sabbour
    Consultant Cardiologist, Mediclinic Airport Road Hospital, UAE
  • Dr. Genaro Menoza
    Cardiologist, HF clinic at medical center SXXI IMSS, Mexico

Hotline Highlights Program:

  • HELIOS-B study update
    Speaker: Prof. Tian Zhuang
  • STOP-or-NOT trial, ABYSS trial
    Speaker: Prof. John Amerena
  • Discusses- vutrisiran in patients with ATTR with CM
    Speaker: Dr. Hany Ragi
  • Discusses HELIOS-B study in first and Eliminating Rheumatic heart disease from Africa- how can we do that?
    Speaker: Dr. Hany Ragi
  • The HELIOS-B study update
    Speaker: Dr. Pedro Schwartzmann
  • Discusses updates on late breaking trial STOP-or-NOT
    Speaker: Dr. Pedro Schwartzmann
  • Talks about FINEARTS-HF and its clinical implication
    Speaker: Prof. David Sim
  • Discusses HELIOS-B study update
    Speaker: Dr. Ramzi Tabbalat
  • Talks about the STEP program update
    Speaker: Dr. Mikhail Kosiborod
  • Discusses the FINEARTS-HF update
    Speaker: Dr. Mikhail Kosiborod

Guideline Highlights Program:

  • The 2024 ESC Guidelines for the Management of Elevated BP and Hypertension
    Speaker: Dr. Alta Schutte and Dr. Markus Schlaich
  • The 2024 ESC Guidelines for the Management of Chronic Coronary Syndromes
    Speaker: Dr. Jagdish Mohan

Hypertension Highlights Program:

  • Timing of antihypertensive treatment: The BedMed and BedMed-Frail RCTs
    Speaker: Dr. Alta Schutte and Dr. Markus Schlaich
  • Discuss FDC in antihypertensive treatment: GMRx2 and QUADRO
    Speaker: Dr. Alta Schutte and Dr. Markus Schlaich

Heart Failure Highlights Program:

  • New updates from GLP studies
    Speaker: Dr. Hani Sabbour
  • Biomarkers to guide the treatment of heart failure: Where are we going?
    Speaker: Dr. Hani Sabbour
  • Updates from STEP program
    Speaker: Dr. Subodh Verma
  • Discusses evidence in HF and call to action from ESC 2024
    Speaker: Dr. Subodh Verma

Coronary Artery Highlights Program:

  • Discusses the effects of Coronary Artery Calcium-Guided Statin Therapy on Atherosclerotic Progression in Intermediate-Risk People with Familial Coronary Artery Disease
    Speaker: Dr. Manuel Gaxiola